TD Asset Management’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-302,000
Closed -$486K 1382
2024
Q3
$486K Buy
+302,000
New +$486K ﹤0.01% 1302